Actually, very few brokerages extend margin on SCMP. The highest I've seen is 70% (so you can only margin 30%). So unlikely to change anything.
This dip just makes it cheaper without affecting the valuation. None of the fundamentals have changed.
All that has changed is that other people own 4M of the shares. Hopefully this will give shareholders more stability because if it is across 50 people, they aren't all going to dump at once.
All in all though, nothing has changed about this company. EPS is still the same. This isn't a dilutive offering, they didn't invent new shares, they just sold some of what they had while maintaining a large amount of shares.
Wow, don't fight the Cramer. He says to sell ISIS and everybody does. #$%$? A bunch of mindless minions. ISIS story, fundamentals, prospects are all still in tact.
I wonder how much of a pullback before Cramer is back on the ISIS bandwagon?
Give him credit for telling people to take some profit$ off the table. That was the reason for the drop on Friday. Next week should channel, then back up.
Of course he is still talking up ISIS because they still have the richest pipeline in the business. Nothing has changed. The long term picture is exactly the same, so why do you think he would change?
Here's a hint, he is likely to be talking up ISIS for the next FIVE YEARS as it rises from $70/share to $700/share.
With the institutional ownership so high, it stands to reason that if all the smart money is long, only the stupid people are short/against it. This is why the institutions make so much money. Watch them ride this to $500/share.
$2.74 EPS and a growth rate of 75%-85% would put shave valuations around $205.50/share, but let's go with a more conservative P/E ratio of 50 and we get a very conservative present value of $137/share.
Even projecting forward for 2015-2016 with EPS of $3.84 and a growth rate of 40% yields a valuation of $153.60/share.
It isn't over until Adam #$%$-Stein says its over. He has LOTS of misinformation to spread, lots of innuendos to make, and a lot of unsubstantiated allegations to write about.
It is far from over. He still has a lot of people to hurt.
The original study filing clearly shows that the study was designed to be a 38-week study all along, right from the very beginning.
This is just another example of where TheStreet intentionally misrepresents the truth and twists things around in order to manipulate the stock price.
Not at all. They released reality. Some cannot comprehend that, but that is what it is.
ISIS has been very honest about side effects with Kynamro as well as stopping earlier drugs that didn't meet the endpoints so they have a proven track record of being up front when the news was bad.
Look for money to flood back into Biotechs as sector after sector warn, like SSYS in the 3-D printer space, oil and energy stocks, etc. The old steady growers are in trouble.
Just look at Radio Shack.
1) hold it for a while and you will sing a very different story. We will be at $75 before Feb 20.
2) Cramer didn't force you to buy the stock, you bought it yourself. Take responsibility for your own decisions. Otherwise, go give your money to a fund manager.
3) You say you promised yourself to never be taken in AGAIN? So this has happened before, repeatedly, have you ever thought that maybe it's YOU and not him?
4) What price did you buy in at? Certainly not at the high, nobody is that stupid. Before you answer consider that every time Cramer recommends this stock it goes up a few dollars a share. This has been true since $30/share and will still be true in a few more the at $90/share. My point is, if you bought on his recommendation it probably went up for a few days first. If you waited, then it was your own slow action, not his recommendation, that is to blame.
5) Hold for just a few months and watch it go up, probably to around $90/share by July if not sooner based on the multiple upward earnings revisions. Then we expect you to post here about what a genius Cramer is.
You've made a very astute observation. The stock wouldn't go to $1,000/share without splitting. Today's market cap of about $8B would / could / should rise to a market cap of $118B.
I believe a stock should split 2-1 whenever it is sustained above $100/share. So that means we need to talk market cap, not share price. In short, we could see the value increase more than 14x in the next 5-years. So an investment of $10,000 would rise to $140,000 and an investment of $100,000 would rise to $1,400,000.
A nice return no matter how you look at it.
Looking at the pipeline that ISIS has, calculating the potential market value of each drug (with normal market penetration, not unseating a dominant market player, but what can be expected), factored by the probability of approval (different for each drug, none higher than 70% probability, some as low as 10%), I come out with a potential value for ISIS in excess of $1000/share. Now it will take 5 years + to get there, but this is why people are scooping up shares. Because it has that kind of a payback potential.